Advertisement

Allergan Gets OK to Market Ocuflox

August 04, 1993

IRVINE — Allergan Inc. said Tuesday that it has received U.S. Food and Drug Administration marketing clearance for its Ocuflox solution. Ocuflox is a topical anti-infective agent for bacteria that cause inflammation of membranes surrounding the eye. The company said it plans to launch Ocuflox in America by the end of the year.

The company said it currently sells the solution in Australia, Brazil, France, Greece, Italy, South Africa and the United Kingdom; approval in Canada and Spain is pending.

The company's stock rose 12.5 cents Tuesday to close at $22.625 on the New York Stock Exchange.

Advertisement
Los Angeles Times Articles
|
|
|